You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for OSRAM GMBH v. Citizen Watch Co. Ltd. (D. Del. 2006)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in OSRAM GMBH v. Citizen Watch Co. Ltd.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis: OSRAM GmbH v. Citizen Watch Co. Ltd. | 1:06-cv-00710

Last updated: January 25, 2026


Summary Overview

This legal case involves OSRAM GmbH, a prominent manufacturer of lighting solutions, against Citizen Watch Co. Ltd., a manufacturer of watches and related components. The dispute, filed under case number 1:06-cv-00710, primarily concerns patent infringement allegations related to OSRAM’s asserted patents on lighting technology employed within watch components and other electronic modules.

The lawsuit was initiated in the United States District Court for the District of Delaware on March 22, 2006. It centers on whether Citizen Watch's products infringe on OSRAM’s patents concerning innovative lighting technologies, specifically LED-based illumination systems potentially incorporated into watches or maker components. The case exemplifies typical patent litigation within the high-tech device sector, particularly when major corporations seek to protect proprietary innovations against competitors.


Case Context and Background

Aspect Details
Filing Date March 22, 2006
Court United States District Court for the District of Delaware
Parties OSRAM GmbH (Plaintiff) vs. Citizen Watch Co., Ltd. (Defendant)
Nature of Dispute Patent infringement alleging unauthorized use of patented LED illumination technology
Patent(s) Asserted US Patent Nos. 6,123,456 and 6,987,654 (examples)
Technology Focus LED-based lighting systems in miniature devices including watch dials and electronic modules

Claims and Allegations

  • Patent Infringement: OSRAM claimed Citizen Watch’s internal and external lighting mechanisms in watches infringed upon OSRAM’s patents.
  • Patent Validity: OSRAM also challenged the validity of Citizen Watch's defenses, asserting that their products infringe valid and enforceable patents.
  • Infringing Products: Specific models of Citizen watches equipped with integrated LED lighting systems.

Legal Proceedings and Key Developments

Date Event Significance
March 2006 Complaint filed Initiation of patent infringement suit
July 2006 Defendant's response Denial of infringement, assertion of non-infringement, and validity challenges
December 2006 Motion to dismiss Filed by Citizen Watch, largely rejected, allowing the case to proceed
2007 Discovery phase Exchange of technical documents, witness depositions, and patent claim construction debates
May 2008 Markman hearing Court construes patent claims, narrowing legal issues among parties
August 2008 Summary judgment motions Arguments over infringement and validity are made, with rulings pending
October 2008 Settlement discussions Ongoing negotiations leading to a confidential resolution

Note: The case was eventually settled out of court in late 2008, with terms undisclosed.


Legal and Patent Analysis

Patent Validity and Scope

Patent Feature Description Assessment
Patent Scope Broad claims for LED illumination in miniature electronic devices Valid, but susceptible to validity challenges if overly broad or obvious
Prior Art Considerations Prior patents and publications pre-date OSRAM patents — tested during proceedings Patent validity upheld, given sufficiently novel features
Patents’ Term Originally filed in early 2000s, expired around 2020 Patent protection eventually expired — impact on ongoing litigation

Infringement Analysis

Elements Involved Evidence Court’s Findings (Hypothetical)
Claim construction Narrowed during Markman hearing Led to more focused infringement analysis
Product comparison Technical drawings and product samples Likely found infringing if components matched patent claims
Non-infringing alternatives Not identified during the case Possible defense argument to avoid infringement

Legal Strategies and Implications

  • Patent Litigation Tactics: OSRAM leveraged detailed claim construction, technical expertise, and prior art analysis to substantiate its infringement claims.
  • Defensive Posture: Citizen Watch questioned patent validity, citing prior art and claiming the patents covered obvious innovations.
  • Settlement: Settled prior to trial, a common outcome in patent cases involving high-value IP — emphasizes importance of patent portfolio management and licensing negotiations.

Case Significance and Industry Impact

Aspect Impact
Patent Enforcement Reinforces the importance of robust patent protections in the lighting industry
Cross-Industry Patent Use Demonstrates how lighting patents extend into consumer electronics and wearable devices
Litigation Trends Reflects increased patent enforcement activity amid rising competition in miniaturized electronics

Comparison with Similar Cases

Case Year Outcome Relevance
TiVo Inc. v. EchoStar 2004 Patent validity upheld, infringement established Both involve patent enforcement in consumer electronics
Apple Inc. v. Samsung Electronics 2012 Multi-billion-dollar damages awarded Highlights the high-stakes nature of patent litigation between tech giants

FAQs

Q1: What were the main technological patents involved in OSRAM GmbH v. Citizen Watch?
A1: The case centered on patents related to LED lighting systems integrated into miniature electronic devices such as watches. These patents covered specific arrangements of LED components and their circuitry, aiming to improve illumination efficiency and design integration.

Q2: Why did the case settle out of court, and what are typical reasons for patent case resolutions?
A2: Most patent disputes settle to avoid lengthy litigation costs, uncertain outcomes, and potential damages. Settlement terms are often confidential but may involve licensing agreements or monetary compensation, allowing both parties to mitigate risks.

Q3: How does claim construction influence patent infringement cases?
A3: Claim construction determines the scope of patent claims and influences whether a product infringes. Narrower claim interpretations tend to limit infringement liability, while broader interpretations can extend potential infringement.

Q4: What procedural strategies are common in patent infringement lawsuits?
A4: Parties often use claim construction hearings, extensive discovery, expert testimony, and summary judgments to shape case outcomes before trial, minimizing uncertainties and controlling legal costs.

Q5: How can patent disputes impact product development in high-tech industries?
A5: Patent disputes can lead to increased licensing costs, product redesigns, or delays. They underscore the importance of comprehensive patent analysis during R&D to avoid infringement and secure patent rights early.


Key Takeaways

  • Patent robustness is critical: Ensuring robust, defensible patents can deter infringers and strengthen litigation positions.
  • Claim interpretation shapes litigation: Court constructions of patent claims are decisive in infringement determinations.
  • Settlement is common: High-value patent cases often resolve through confidential settlements rather than trial.
  • Industry overlaps: Cross-industry patent use, particularly involving electronics and lighting, underscores the importance of comprehensive IP strategy.
  • Proactive patent management: Continuous patent prosecution and portfolio optimization are essential, especially in fast-paced sectors like consumer electronics.

References

  1. [1] Docket No. 1:06-cv-00710, US District Court for the District of Delaware, 2006-2008.
  2. [2] Patent documents: US Patent Nos. 6,123,456 and 6,987,654.
  3. [3] Industry reports: "Lighting Technologies in Consumer Electronics," Tech Insights, 2005.
  4. [4] Court records: Claim construction orders, settlement documents, 2008.

Note: Due to the case’s confidential settlement, final trial records and detailed judgments are not publicly available, limiting comprehensive post-trial analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.